Nonaka et al. (2019) studies revealed that this gain of function mutation is associated with alternations in calcium/NFATc1 signaling pathway, which in turn accelerates chondrogenic and osteogenic differentiation of DPSCs causing the congenital skeletal disease (Han et al., 2020). The gene discussed is NFATC1; the disease is bone disorder.